Priscilla K Brastianos

Priscilla K Brastianos

UNVERIFIED PROFILE

Are you Priscilla K Brastianos?   Register this Author

Register author
Priscilla K Brastianos

Priscilla K Brastianos

Publications by authors named "Priscilla K Brastianos"

Are you Priscilla K Brastianos?   Register this Author

92Publications

3013Reads

9Profile Views

In Reply: A Clinical Rule for Preoperative Prediction of BRAF Mutation Status in Craniopharyngiomas.

Neurosurgery 2019 Nov;85(5):E966

Divisions of Neuro-Oncology and Hematology/Oncology Departments of Medicine and Neurology Massachusetts General Hospital Cancer Center Harvard Medical School Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuros/nyz327DOI Listing
November 2019

Management of leptomeningeal carcinomatosis and challenges of trial design.

Curr Opin Oncol 2019 Nov;31(6):508-513

Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000574DOI Listing
November 2019

Targeted treatment of papillary craniopharyngiomas harboring BRAF V600E mutations.

Cancer 2019 Sep 17;125(17):2910-2914. Epub 2019 Jul 17.

Divisions of Neuro-Oncology and Hematology/Oncology, Departments of Neurology and Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32197DOI Listing
September 2019

An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma.

Cell 2019 Aug 18;178(4):835-849.e21. Epub 2019 Jul 18.

Department of Pathology and Center for Cancer Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA; Klarman Cell Observatory, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2019.06.024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6703186PMC
August 2019

Clinical Validation of a Cell-Free DNA Gene Panel.

J Mol Diagn 2019 Jul 23;21(4):632-645. Epub 2019 Apr 23.

Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2019.02.008DOI Listing
July 2019

Increased risk of brain metastases in ovarian cancer patients with BRCA mutations.

Gynecol Oncol 2019 06 12;153(3):568-573. Epub 2019 Mar 12.

Harvard Medical School, Hematology/Oncology, Massachusetts General Hospital, 55 Fruit Street, Yawkey 9E, Boston, MA 02114, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2019.03.004DOI Listing
June 2019

The Development of Brain Metastases in Patients with Renal Cell Carcinoma: Epidemiologic Trends, Survival, and Clinical Risk Factors Using a Population-based Cohort.

Eur Urol Focus 2019 May 5;5(3):474-481. Epub 2018 Jan 5.

Lank Center for Genitourinary Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euf.2017.12.007DOI Listing
May 2019

Precision Medical Approaches to the Diagnoses and Management of Brain Metastases.

Curr Treat Options Oncol 2019 May 6;20(6):49. Epub 2019 May 6.

Department of Medical Oncology, Division of Neuro-Oncology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-019-0649-yDOI Listing
May 2019

Recent advances in managing brain metastasis.

F1000Res 2018 9;7. Epub 2018 Nov 9.

Department of Radiation Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, FL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12688/f1000research.15903.1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234720PMC
March 2019

Targeting Molecular Pathways in Intracranial Metastatic Disease.

Front Oncol 2019 4;9:99. Epub 2019 Mar 4.

Divisions of Neuro-Oncology and Hematology/Oncology, Departments of Neurology and Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2019.00099DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409309PMC
March 2019

New molecular targets in meningiomas: the present and the future.

Curr Opin Neurol 2018 12;31(6):740-746

Divisions of Neuro-Oncology and Hematology/Oncology, Departments of Neurology and Medicine, Massachusetts General Hospital/Harvard Medical School.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00019052-201812000-0001
Publisher Site
http://dx.doi.org/10.1097/WCO.0000000000000615DOI Listing
December 2018

Seminoma with Neoplastic Meningitis Treated with Craniospinal Irradiation.

Oncologist 2018 11 16;23(11):1385-1387. Epub 2018 Jul 16.

Divisions of Hematology/Oncology and Neuro-Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
http://theoncologist.alphamedpress.org/lookup/doi/10.1634/th
Publisher Site
http://dx.doi.org/10.1634/theoncologist.2017-0223DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6291321PMC
November 2018

Updates in prognostic markers for gliomas.

Neuro Oncol 2018 11;20(suppl_7):vii17-vii26

Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
https://academic.oup.com/neuro-oncology/article/20/suppl_7/v
Publisher Site
http://dx.doi.org/10.1093/neuonc/noy158DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225747PMC
November 2018

TERT Alterations in Progressive Treatment-Resistant Meningiomas.

Neurosurgery 2018 09;65(CN_suppl_1):66-68

Translational Neuro-Oncology Labora-tory, Department of Neurosurgery, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuros/nyy154DOI Listing
September 2018

Personalized medicine in brain metastases: a plea for more translational studies.

Per Med 2018 05 25;15(3):141-143. Epub 2018 May 25.

Divisions of Hematology/Oncology & Neuro-Oncology, Departments of Medicine & Neurology, Massachusetts General Hospital, Boston, MA, 02114, USA.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/pme-2017-0087
Publisher Site
http://dx.doi.org/10.2217/pme-2017-0087DOI Listing
May 2018

The Evolving Landscape of Brain Metastasis.

Trends Cancer 2018 03 21;4(3):176-196. Epub 2018 Feb 21.

Department of Neuro-Oncology, University Hospital Turin, Via Cherasco 15, 10126 Turin, Italy. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S24058033183001
Publisher Site
http://dx.doi.org/10.1016/j.trecan.2018.01.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6602095PMC
March 2018

Advances in meningioma genetics: novel therapeutic opportunities.

Nat Rev Neurol 2018 02 5;14(2):106-115. Epub 2018 Jan 5.

Department of Neuropathology, Otto von Guericke University Magdeburg, Leipziger Strasse, 44, 39120 Magdeburg, Germany.

View Article

Download full-text PDF

Source
http://www.nature.com/doifinder/10.1038/nrneurol.2017.168
Publisher Site
http://dx.doi.org/10.1038/nrneurol.2017.168DOI Listing
February 2018

A Hematogenous Route for Medulloblastoma Leptomeningeal Metastases.

Cell 2018 02;172(5):1050-1062.e14

Developmental and Stem Cell Biology Program, The Hospital for Sick Children, Toronto, ON, Canada; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON, Canada; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada; Division of Neurosurgery, The Hospital for Sick Children, Toronto, ON, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2018.01.038DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346737PMC
February 2018

Toward Precision Medicine in Brain Metastases.

Semin Neurol 2018 02 16;38(1):95-103. Epub 2018 Mar 16.

Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0038-1627469DOI Listing
February 2018

Leptomeningeal metastasis from systemic cancer: Review and update on management.

Cancer 2018 Jan 22;124(1):21-35. Epub 2017 Nov 22.

Division of Neuro-Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30911DOI Listing
January 2018

Genetic Characterization of Brain Metastases in the Era of Targeted Therapy.

Front Oncol 2017 25;7:230. Epub 2017 Sep 25.

Departments of Neurology and Radiation Oncology, Division of Hematology/Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2017.00230DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622141PMC
September 2017

Targeted sequencing of SMO and AKT1 in anterior skull base meningiomas.

J Neurosurg 2017 08 25;127(2):438-444. Epub 2016 Nov 25.

Department of Neurosurgery, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3171/2016.8.JNS161076DOI Listing
August 2017

Sequencing brain metastases and opportunities for targeted therapies.

Pharmacogenomics 2017 Apr 14;18(6):585-594. Epub 2017 Mar 14.

Division of Hematology & Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs-2016-0170DOI Listing
April 2017

Immunotherapy and targeted therapy in brain metastases: emerging options in precision medicine.

CNS Oncol 2017 04;6(2):139-151

Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital, Boston, MA 02144, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/cns-2016-0038DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020878PMC
April 2017

SMO mutant olfactory groove meningiomas-the next in line for targeted therapy.

Neuro Oncol 2017 03;19(3):305-306

Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

View Article

Download full-text PDF

Source
https://academic.oup.com/neuro-oncology/article-lookup/doi/1
Publisher Site
http://dx.doi.org/10.1093/neuonc/now302DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5464315PMC
March 2017

Treatment of brain metastases in the modern genomic era.

Pharmacol Ther 2017 02 20;170:64-72. Epub 2016 Oct 20.

Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States; Cancer Center, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States; Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pharmthera.2016.10.011DOI Listing
February 2017

Clinical Activity of Alectinib in Advanced RET-Rearranged Non-Small Cell Lung Cancer.

J Thorac Oncol 2016 11 17;11(11):2027-2032. Epub 2016 Aug 17.

Massachusetts General Hospital Cancer Center, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.08.126DOI Listing
November 2016

Novel approaches in genetic characterization and targeted therapy for brain metastases.

Discov Med 2016 11;22(122):237-250

Department of Hematology and Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
November 2016

A new patient-derived orthotopic malignant meningioma model treated with oncolytic herpes simplex virus.

Neuro Oncol 2016 09 6;18(9):1278-87. Epub 2016 Mar 6.

Department of Neurosurgery (F.N., S.-i.E., M.H., N.L., D.P.C., S.D.R., R.L.M., H.W.), Center for Human Genetic Research (M.F.J., V.R.), Department of Neuropathology (A.S.-R.), Division of Neuro-Oncology (P.K.B.), Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4998993PMC
September 2016

Brain Metastasis: Clinical Implications of Branched Evolution.

Trends Cancer 2016 07 29;2(7):332-337. Epub 2016 Jun 29.

Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA; Cancer Program, The Eli and Edythe L. Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA; Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.trecan.2016.06.005DOI Listing
July 2016

: meningioma.

Neurooncol Pract 2016 Jun 13;3(2):120-134. Epub 2016 Jan 13.

Department of Radiation Oncology, University of California, San Francisco, San Francisco, CA, USA (S.E.F.); Department of Radiology, Mayo Clinic, Rochester, MN, USA (D.R.J., T.J.K.); Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA (F.G.B.); Division of Neuro-Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA (P.K.B.); Department of Neurology and Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA (J.L.C.); Department of Neurology, Karl Landsteiner University Clinic, St Pölten, Austria (S.O.); Department of Internal Medicine, Medical University, Vienna, CCC, Austria (M.P.); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA (A.R.); Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA (S.S.); Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA (P.V.T.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nop/npv063DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668267PMC
June 2016

Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma.

Neuro Oncol 2016 05 28;18(5):649-55. Epub 2016 Jan 28.

Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (M.A., P.H.M., R.B., M.L.L., S.H.R., R.D.F., K.L.L., A.H.L., S.S.); Department of Pathology, King Fahad Medical City, Riyadh, Saudi Arabia (M.A.); King Abdulaziz City for Science and Technology, Riyadh, Saudi Arabia (M.A.); Harvard Medical School, Boston, Massachusetts (M.A., A.A.A., D.D.-S., P.K.B., D.A.R., P.Y.W., O.A.-M., S.H.R., R.D.F., K.L.L., A.H.L., B.M.A., I.F.D., R.B., S.S.); Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts (W.L.B., O.A.-M., I.F.D.); Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts (A.A.A., B.M.A.); Department of Neurosurgery, Massachusetts General Hospital, Boston, Massachusetts (P.K.A.); Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts (D.D.-S.); Center for Cancer Genomic Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts (A.R.T., P.V.H.); Department of Neuro-Oncology, Massachusetts General Hospital, Boston, Massachusetts (P.K.B.); Center of Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (D.A.R., P.Y.W, R.B.); Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts (K.L.L., R.B.); Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA (S.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nov316DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827048PMC
May 2016

ENDOCRINE TUMORS: BRAF V600E mutations in papillary craniopharyngioma.

Eur J Endocrinol 2016 Apr 12;174(4):R139-44. Epub 2015 Nov 12.

Division of Neuro-OncologyMassachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USADepartment of Cancer BiologyDana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02215, USADepartment of PathologyBrigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, 77 Avenue Louis Pasteur, Boston, Massachusetts 02115, USADepartment of PathologyBoston Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA Division of Neuro-OncologyMassachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USADepartment of Cancer BiologyDana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02215, USADepartment of PathologyBrigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, 77 Avenue Louis Pasteur, Boston, Massachusetts 02115, USADepartment of PathologyBoston Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA Division of Neuro-OncologyMassachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USADepartment of Cancer BiologyDana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02215, USADepartment of PathologyBrigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, 77 Avenue Louis Pasteur, Boston, Massachusetts 02115, USADepartment of PathologyBoston Children's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/EJE-15-0957DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876601PMC
April 2016

Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy.

J Natl Cancer Inst 2016 Feb 23;108(2). Epub 2015 Oct 23.

Department of Medicine (PKB, RS), Department of Neurology (PKB, CMG), Department of Neurosurgery (GMS, PJ, BN, DPC, WTC, FGB), Department of Surgical Oncology (DTF), Department of Pathology (GG, DNL), Cancer Center (PKB, CMG, NN, DNL), Department of Radiology (JR) Massachusetts General Hospital, Harvard Medical School, Boston, MA; Broad Institute (ATW, GG), Department of Pathology, (MA, SS) and Department of Neurosurgery, Brigham and Women's Hospital (IFD), Boston, MA; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA (DJP).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv310DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862417PMC
February 2016

Systemic therapy of brain metastases.

Curr Neurol Neurosci Rep 2015 ;15(2):518

Department of Radiation Oncology, Queen's University, Kingston, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11910-014-0518-9DOI Listing
July 2015

Genomic profiling of brain metastases: current knowledge and new frontiers.

Chin Clin Oncol 2015 Jun;4(2):22

Division of Neuro-Oncology, Stephen E. and Catherine Pappas Center for Neuro-Oncology, Harvard Medical School, 55 Fruit Street, Yawkey 9E, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2304-3865.2015.06.04DOI Listing
June 2015

PLEKHA5: A Key to Unlock the Blood-Brain Barrier?

Clin Cancer Res 2015 May 16;21(9):1978-80. Epub 2015 Mar 16.

Division of Neuro-Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-2604DOI Listing
May 2015

Management of brain metastases in the era of targeted and immunomodulatory therapies.

Oncology (Williston Park) 2015 Apr;29(4):261-3

View Article

Download full-text PDF

Source
April 2015

Alectinib salvages CNS relapses in ALK-positive lung cancer patients previously treated with crizotinib and ceritinib.

J Thorac Oncol 2015 Feb;10(2):232-6

*Department of Medicine, Massachusetts General Hospital, Boston, MA; †Department of Medicine, Medical University of South Carolina, Charleston, SC; and ‡Department of Neurology, Massachusetts General Hospital, Boston, MA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864153232
Publisher Site
http://dx.doi.org/10.1097/JTO.0000000000000455DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304931PMC
February 2015

Molecular typing of Meningiomas by Desorption Electrospray Ionization Mass Spectrometry Imaging for Surgical Decision-Making.

Int J Mass Spectrom 2015 Feb;377:690-698

Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115 ; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115 ; Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115.

View Article

Download full-text PDF

Source
http://dunnlab.bwh.harvard.edu/wp-content/uploads/2015/05/Ca
Web Search
http://linkinghub.elsevier.com/retrieve/pii/S138738061400250
Publisher Site
http://dx.doi.org/10.1016/j.ijms.2014.06.024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4379512PMC
February 2015

Predictive molecular markers in metastases to the central nervous system: recent advances and future avenues.

Acta Neuropathol 2014 Dec 7;128(6):879-91. Epub 2014 Oct 7.

Department of Medicine 1 and Comprehensive Cancer Center Vienna, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00401-014-1350-7DOI Listing
December 2014

Analysis of tumour- and stroma-supplied proteolytic networks reveals a brain-metastasis-promoting role for cathepsin S.

Nat Cell Biol 2014 Sep 3;16(9):876-88. Epub 2014 Aug 3.

1] Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA [2] Brain Tumor Center, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA [3] Metastasis Research Center, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncb3011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4249762PMC
September 2014

Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas.

Nat Genet 2014 Feb 12;46(2):161-5. Epub 2014 Jan 12.

1] Harvard Medical School, Boston, Massachusetts, USA. [2] Department of Pathology, Boston Children's Hospital, Boston, Massachusetts, USA. [3] Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA. [4] Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [5].

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ng.2868DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3982316PMC
February 2014

Clinical discussion and review of the management of brain metastases.

J Natl Compr Canc Netw 2013 Sep;11(9):1153-64

From the aDepartment of Medicine, Division of Hematology/Oncology, bDepartment of Neurosurgery, and cDepartment of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2013.0133DOI Listing
September 2013

Radiation Treatment for WHO Grade II and III Meningiomas.

Front Oncol 2013 Sep 2;3:227. Epub 2013 Sep 2.

Department of Neurological Surgery, Massachusetts General Hospital, Harvard Medical School , Boston, MA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2013.00227DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759290PMC
September 2013

Primary central nervous system lymphoma: overview of current treatment strategies.

Hematol Oncol Clin North Am 2012 Aug;26(4):897-916

Stephen E. and Catherine Pappas Center for Neuro-Oncology, Division of Hematology and Oncology, Department of Neurology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2012.05.003DOI Listing
August 2012

The toxicity of intrathecal bevacizumab in a rabbit model of leptomeningeal carcinomatosis.

J Neurooncol 2012 Jan 26;106(1):81-8. Epub 2011 Jul 26.

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Smith 353, Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-011-0655-9DOI Listing
January 2012

Prognostic and predictive value of epigenetic silencing of MGMT in patients with high grade gliomas: a systematic review and meta-analysis.

J Neurooncol 2011 Nov 27;105(2):325-35. Epub 2011 Apr 27.

Centre for North, Department of Radiation Oncology, University of British Columbia and British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, BC, V5Z 4E6, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-011-0594-5DOI Listing
November 2011

Vascular endothelial growth factor inhibitors in malignant gliomas.

Target Oncol 2010 Sep 7;5(3):167-74. Epub 2010 Sep 7.

Stephen E. and Catherine Pappas Center for Neuro-Oncology, Department of Neurology, Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11523-010-0158-1DOI Listing
September 2010

VEGF inhibitors in brain tumors.

Clin Adv Hematol Oncol 2009 Nov;7(11):753-60, 768

Department of Medical Oncology, Dana-Farber/Brigham and Women's Cancer Center, Massachusetts General Hospital, Boston, 02114, USA.

View Article

Download full-text PDF

Source
November 2009

Tuberculosis-associated haemophagocytic syndrome.

Lancet Infect Dis 2006 Jul;6(7):447-54

Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21231-1002, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1473-3099(06)70524-2DOI Listing
July 2006